Adam Kurkiewicz
About Adam Kurkiewicz
Adam Kurkiewicz serves as the Head of Bioinformatics at Parse Biosciences in Berlin, Germany, where he has worked since 2023. He has a background in bioinformatics, having previously held positions at the University of Glasgow and Biomage Ltd, and has contributed significantly to the field of single-cell transcriptomics.
Work at Parse
Adam Kurkiewicz serves as the Head of Bioinformatics at Parse Biosciences, a position he has held since 2023. He operates remotely from Berlin, Germany. In this role, he leads bioinformatics initiatives and teams, leveraging his expertise to advance the company's objectives in the field of bioinformatics.
Previous Experience
Before joining Parse Biosciences, Adam held several significant positions. He was the Chief Executive Officer at Biomage Ltd from 2019 to 2024, where he contributed to the company's strategic direction. Additionally, he worked as a Contractor at Harvard Medical School from 2020 to 2022, gaining valuable experience in a prestigious academic environment. His early career included a six-year tenure as a PhD student at the University of Glasgow from 2016 to 2022.
Education and Expertise
Adam Kurkiewicz completed his education at the University of Glasgow, where he earned both a Bachelor of Science and a PhD from 2011 to 2021. His academic background provides a strong foundation for his work in bioinformatics, particularly in the area of single-cell transcriptomics.
Contributions to Single-Cell Transcriptomics
Adam played a significant role in the development of Cellenics, a platform recognized as a gold standard in single-cell transcriptomics. His contributions facilitated its adoption by key opinion leaders associated with the Human Cell Atlas and its use in approximately 3000 laboratories worldwide.
Leadership in Bioinformatics
Adam has demonstrated his capability in leading bioinformatics teams remotely. His current role at Parse Biosciences reflects his experience and skills in managing teams and projects in a digital environment, showcasing his adaptability in the evolving landscape of bioinformatics.